Literature DB >> 19329337

Lack of nuclear translocation of cytoplasmic domains of IL-2/IL-15 receptor subunits.

Hodaka Fujii1, Akemi Hoshino.   

Abstract

Some sensors of extracellular signaling molecules such as Notch and sterol response element binding protein (SREBP) receive ligand-induced intra-membrane proteolysis followed by nuclear translocation of their cytoplasmic domains to regulate gene expression programs in the nucleus. It has not been extensively examined whether ligand-induced intra-membrane proteolysis of type I cytokine receptors and nuclear translocation of cytoplasmic domains occur. Here, by using a sensitive reporter system, we examined this possibility for the interleukin-2 (IL-2) receptor (IL-2R) beta-chain (IL-2R beta) and the IL-15 receptor (IL-15R) alpha-chain (IL-15R alpha). Flowcytometric analysis revealed that ligand stimulation does not induce nuclear translocation of their cytoplasmic domains. In addition, overexpression of the cytoplasmic domain of the common cytokine receptor gamma-chain (gamma c) in an IL-2R-reconstituted Ba/F3-derived cell line did not affect any biological responses including cell survival, disproving potential roles of the cleaved cytoplasmic domain of gamma c as a signal transducer. Collectively, these results indicated that potential nuclear function of cleaved type I cytokine receptor subunits is not plausible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329337      PMCID: PMC2693279          DOI: 10.1016/j.cyto.2009.02.014

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  20 in total

Review 1.  Signal transduction and the control of gene expression.

Authors:  Ali H Brivanlou; James E Darnell
Journal:  Science       Date:  2002-02-01       Impact factor: 47.728

Review 2.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

3.  Inducible translocation trap: a system for detecting inducible nuclear translocation.

Authors:  Akemi Hoshino; Satoko Matsumura; Kimie Kondo; John A Hirst; Hodaka Fujii
Journal:  Mol Cell       Date:  2004-07-02       Impact factor: 17.970

Review 4.  Cytokine signaling through nonreceptor protein tyrosine kinases.

Authors:  T Taniguchi
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

5.  Cloning of the gamma chain of the human IL-2 receptor.

Authors:  T Takeshita; H Asao; K Ohtani; N Ishii; S Kumaki; N Tanaka; H Munakata; M Nakamura; K Sugamura
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

6.  Calcium depletion dissociates and activates heterodimeric notch receptors.

Authors:  M D Rand; L M Grimm; S Artavanis-Tsakonas; V Patriub; S C Blacklow; J Sklar; J C Aster
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.

Authors:  T Miyazaki; A Kawahara; H Fujii; Y Nakagawa; Y Minami; Z J Liu; I Oishi; O Silvennoinen; B A Witthuhn; J N Ihle
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

8.  IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc.

Authors:  H Shibuya; M Yoneyama; J Ninomiya-Tsuji; K Matsumoto; T Taniguchi
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

9.  Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.

Authors:  J G Giri; M Ahdieh; J Eisenman; K Shanebeck; K Grabstein; S Kumaki; A Namen; L S Park; D Cosman; D Anderson
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

10.  The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.

Authors:  Benjamin J Thompson; Silvia Buonamici; Maria Luisa Sulis; Teresa Palomero; Tomas Vilimas; Giuseppe Basso; Adolfo Ferrando; Iannis Aifantis
Journal:  J Exp Med       Date:  2007-07-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.